Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mysimba for Weight Regain After Bariatric Surgery
NCT04902625Phase 4Unknown
- Sponsor
- Zuyderland
- Start
- Mar 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone + bupropion in obesity, sponsored by Zuyderland. Status: unknown.
02
Drugs
naltrexone + bupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04902625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04902625.